Can CYP2C19 help with skin aging?

CYP2C19 is a cytochrome P450 enzyme primarily involved in drug metabolism (e.g., clopidogrel, proton pump inhibitors). There is no robust scientific evidence directly linking CYP2C19 variants to skin aging. Hypothetical connections via oxidative stress or inflammation remain speculative and lack clinical validation. Direct-to-consumer DNA tests that include CYP2C19 typically focus on pharmacogenetics, not dermatological aging. Therefore, the evidence for using CYP2C19 to guide anti-aging interventions is 'unclear'. For skin aging, established factors like UV protection, diet, sleep, and validated biomarkers (e.g., collagen, elastin) are far more relevant. A consumer genetic test cannot provide clinically meaningful insights into skin aging through this gene alone.